Craig-Hallum Maintains NVIDIA(NVDA.US) With Buy Rating
Morgan Stanley Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,106
BMO Capital Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,101
A Quick Look at Today's Ratings for NVIDIA(NVDA.US), With a Forecast Between $145 to $175
Eli Lilly Analyst Ratings
Nvidia Is Maintained at Buy by Truist Securities
Wolfe Research Maintains Microsoft(MSFT.US) With Buy Rating, Cuts Target Price to $495
Truist Adjusts Price Target on NVIDIA to $145 From $140, Maintains Buy Rating
Nvidia Price Target Maintained With a $175.00/Share by Loop Capital
NVIDIA Analyst Ratings
Craig-Hallum Maintains NVIDIA(NVDA.US) With Buy Rating
Morgan Stanley Maintains NVIDIA(NVDA.US) With Buy Rating, Maintains Target Price $144
Loop Capital Maintains NVIDIA(NVDA.US) With Buy Rating, Maintains Target Price $175
Loop Capital Maintains Microsoft(MSFT.US) With Buy Rating, Maintains Target Price $500
New Buy Rating for Nvidia (NVDA), the Technology Giant
Nvidia (NVDA): Analysts Expect 140% Earnings Growth in Q2
Wells Fargo Maintains Microsoft(MSFT.US) With Buy Rating, Maintains Target Price $515
Microsoft's Strong Growth and Clearer Financials Justify Buy Rating
Barclays Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,025
Eli Lilly & Co (LLY) Receives a Buy From Barclays